Literature DB >> 15762878

Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen.

G Ramadan1, B Davies, V P Kurup, C A Keever-Taylor.   

Abstract

Invasive aspergillosis (IA) is a major cause of infection-related mortality in patients with haematological malignancies, especially in recipients of haematopoietic stem cell transplants. We have prepared overlapping pentadecapeptides (11-aa overlap with previous peptide) spanning the entire 427-aa coding region of the Aspergillus allergen, Asp f16 shown previously in mice to induce Th1-type cell responses in vivo and in humans to induce proliferative and cytotoxic CD4(+) T cell responses. Mature dendritic cells (DC) pulsed with a complete pool of peptides were used to generate T cell lines. Two lines from HLA-B*3501(+) donors were found to be strongly cytotoxic to autologous Asp f16-peptide pool- and Aspergillus culture extract-pulsed targets after 4-5 weekly primings. Cytotoxic T lymphocyte (CTL) culture supernatant killed Aspergillus conidia, and cells directly killed Aspergillus hyphae. Cytotoxic activity and interferon (IFN)-gamma production were mediated exclusively by CD8(+) T cells in response to pool-pulsed targets. Interleukin (IL)-4 production was not detected. CTL activity was restricted by HLA-B*3501 and based on peptide prediction programmes was most probably directed to YFKYTAAAL (YFK), LPLCSAQTW (LPL) and GTRFPQTPM (GTR) in one donor, while only LPL was recognized by CTL from the second donor. Pool-pulsed B*3503(+) BLCL but not B*3502(+) or B*3508(+) BLCL presented peptide to donor no. 1. B*3503(+) BLCL presented YFK and to a lesser extent GTR, but not peptide LPL. Our data show that in addition to our previously identified Class II restricted peptide response, DC pulsed with a pentadecapeptide pool from Asp f16 are capable of inducing polyclonal, HLA-Class I-restricted, Aspergillus-specific T cells that may be capable of conferring immunity to IA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15762878      PMCID: PMC1809331          DOI: 10.1111/j.1365-2249.2005.02738.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  54 in total

1.  Characterization of antigens from Aspergillus fumigatus. I. Preparation of antigens from organisms grown in completely synthetic medium.

Authors:  S J Kim; S D Chaparas
Journal:  Am Rev Respir Dis       Date:  1978-09

2.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.

Authors:  K Falk; O Rötzschke; S Stevanović; G Jung; H G Rammensee
Journal:  Nature       Date:  1991-05-23       Impact factor: 49.962

3.  Generation of Th1 T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen.

Authors:  G Ramadan; B Davies; V P Kurup; C A Keever-Taylor
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

4.  Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein.

Authors:  A Bertoletti; F V Chisari; A Penna; S Guilhot; L Galati; G Missale; P Fowler; H J Schlicht; A Vitiello; R C Chesnut
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

5.  Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones.

Authors:  S R Riddell; K S Watanabe; J M Goodrich; C R Li; M E Agha; P D Greenberg
Journal:  Science       Date:  1992-07-10       Impact factor: 47.728

6.  Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC.

Authors:  G Ramadan; S Konings; V P Kurup; C A Keever-Taylor
Journal:  Cytotherapy       Date:  2004       Impact factor: 5.414

Review 7.  Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones.

Authors:  S R Riddell; B A Walter; M J Gilbert; P D Greenberg
Journal:  Bone Marrow Transplant       Date:  1994       Impact factor: 5.483

8.  Asp f I CD4+ TH2-like T-cell lines in allergic bronchopulmonary aspergillosis.

Authors:  A P Knutsen; K R Mueller; A D Levine; B Chouhan; P S Hutcheson; R G Slavin
Journal:  J Allergy Clin Immunol       Date:  1994-08       Impact factor: 10.793

9.  Growth inhibition of Candida albicans hyphae by CD8+ lymphocytes.

Authors:  D W Beno; A G Stöver; H L Mathews
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

Review 10.  Immunodiagnosis of aspergillosis.

Authors:  V P Kurup; A Kumar
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

View more
  12 in total

1.  Generation of functional monocyte-derived fast dendritic cells suitable for clinical application in the absence of interleukin-6.

Authors:  Gamal Ramadan
Journal:  Cytotechnology       Date:  2011-07-16       Impact factor: 2.058

2.  Immune responses induced by heat killed Saccharomyces cerevisiae: a vaccine against fungal infection.

Authors:  Min Liu; Karl V Clemons; Marty Bigos; Izabela Medovarska; Elmer Brummer; David A Stevens
Journal:  Vaccine       Date:  2011-01-08       Impact factor: 3.641

3.  Adoptive immunity mediated by HLA-A*0201 restricted Asp f16 peptides-specific CD8+ T cells against Aspergillus fumigatus infection.

Authors:  Z Sun; P Zhu; L Li; Z Wan; Z Zhao; R Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-14       Impact factor: 3.267

Review 4.  Vaccine immunity against fungal infections.

Authors:  Som G Nanjappa; Bruce S Klein
Journal:  Curr Opin Immunol       Date:  2014-03-03       Impact factor: 7.486

5.  Association of Chlamydia pneumoniae infection with HLA-B*35 in patients with coronary artery disease.

Authors:  Anil Palikhe; Marja-Liisa Lokki; Pekka Saikku; Maija Leinonen; Mika Paldanius; Mikko Seppänen; Ville Valtonen; Markku S Nieminen; Juha Sinisalo
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

6.  Healthy human T-Cell Responses to Aspergillus fumigatus antigens.

Authors:  Neelkamal Chaudhary; Janet F Staab; Kieren A Marr
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

7.  Prophylactic and Therapeutic Potential of Asp f1 Epitopes in Naïve and Sensitized BALB/c Mice.

Authors:  Neelkamal Chaudhary; Lakshna Mahajan; Taruna Madan; Anil Kumar; Gajendra Pratap Singh Raghava; Seturam Bandacharya Katti; Wahajul Haq; Puranam Usha Sarma
Journal:  Immune Netw       Date:  2009-10-30       Impact factor: 6.303

8.  Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses.

Authors:  F Zhu; G Ramadan; B Davies; D A Margolis; C A Keever-Taylor
Journal:  Clin Exp Immunol       Date:  2007-11-14       Impact factor: 4.330

9.  Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy.

Authors:  C R Y Cruz; S Lam; P J Hanley; A S Bear; C Langston; A J Cohen; H Liu; C A Martinez; R A Krance; H E Heslop; C M Rooney; I C Hanson; C M Bollard
Journal:  Clin Exp Immunol       Date:  2013-10       Impact factor: 4.330

10.  Role of germination in murine airway CD8+ T-cell responses to Aspergillus conidia.

Authors:  Steven P Templeton; Amanda D Buskirk; Brandon Law; Brett J Green; Donald H Beezhold
Journal:  PLoS One       Date:  2011-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.